MAY 23, 2018 12:33 AM PDT

Drug Repurposing: Antimalarial Drug Treats Ovarian Cancer in Patient

WRITTEN BY: Nouran Amin

According to a recent published case report, a woman diagnosed with ovarian cancer was lead to recovery after being treated using a therapeutic for a different disease. The case report examined the relationship between the patient’s autoimmune disease and the treatment hoping it might have contributed to achieving such a "striking" response.

Researchers led by Professor of Medicine at NYU Langone's Perlmutter Cancer Center, Dr. Franco Muggia, described a case of a patient who received treatment for dermatomyositis, an autoimmune condition that leads muscle weakness and skin rashes. For this particular condition, the woman received treatment involving hydroxychloroquine and quinacrine, which are antimalarial drugs.However, the patient was later presented with an advanced and aggressive form of ovarian cancer.

Although there are effective treatments, ovarian cancer is known to recur within a median of 18 months to 2 years.

Dr. Muggia's patient surprised doctors with immediate and lasting response to the ovarian cancer treatment. Three years later, and the patient is ovarian-cancer free and dermatomyositis free. The follow-up results were also seen to have no evidence of the symptoms exhibited by these two diseases.

The particular antimalarial drugs, hydroxychloroquine and quinacrine, were previously studied to play a role in cancer treatment. They most likely appear to collaborate with cancer drugs to increase their efficacy.

These antimalarial drugs intended for dermatomyositis, that eventually treated the women’s ovarian cancer, have inspired the medical community to “repurpose” drugs; that is drugs developed to treat one condition were found to be useful for other conditions.

"This is an interesting example of serendipity—an incidental finding of a cancer patient responding strongly to a non-cancer drug used for the treatment of a co-morbid condition," explains Dr. Pan Pantziarka of The Anticancer Fund, Belgium, and one of the leaders of the Repurposing Drugs in Oncology (ReDO) Project. "It's important to publish such cases as they may provide early data for later preclinical and clinical investigation."

Dr. Muggia notes that conclusions from the case reports should not be drawn from the example of her patient. "However, the depth of the response of an aggressive high-grade serous ovarian cancer to the initial platinum-taxane doublet, after months of dermatomyositis and treatment with anti-malarial drugs, should encourage further inquiries into the role of autophagy, its subsequent inhibition, and immunity in enhancing responses to [platinum-based] chemotherapy. There is already strong evidence that anti-malarials such as hydroxychloroquine and chloroquine possess anticancer activity, as was summarized by the ReDO Project last year. If replicated, it would show yet again the therapeutic value still to be realized in so many of our existing non-cancer medicines."

Sources: Medical Xpress

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 22, 2020
Drug Discovery & Development
Could a Drug for Bipolar Disorder Treat COVID-19?
AUG 22, 2020
Could a Drug for Bipolar Disorder Treat COVID-19?
Researchers have found that a drug currently used to treat bipolar disorder and hearing loss may also treat COVID-19 tha ...
AUG 24, 2020
Immunology
Injectable Drug Stops HIV From Entering Cells
AUG 24, 2020
Injectable Drug Stops HIV From Entering Cells
Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself w ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 11, 2020
Drug Discovery & Development
Treating Connective Tissue Disorders
OCT 11, 2020
Treating Connective Tissue Disorders
Collaborative research efforts are geared to improving disease that affects connective tissues via innovative drug deliv ...
OCT 23, 2020
Drug Discovery & Development
Common Asthmatic Treatments Increase Risk of Bone Fractures
OCT 23, 2020
Common Asthmatic Treatments Increase Risk of Bone Fractures
A study published in the journal Thorax found that taking steroid inhalers or tablets for asthma treatment to control fl ...
Loading Comments...